Dr. Agarwal’s Health Care Limited has received a certificate from KFin Technologies Limited, the Registrar and Share Transfer Agent, for the quarter ended December 31, 2025 (Q3 2026). The certificate confirms compliance with SEBI regulations concerning the dematerialization or rematerialization of securities during the specified period. This ensures adherence to regulatory requirements and transparency for investors.
Compliance Confirmation for Q3 2026
Dr. Agarwal’s Health Care Limited announced the receipt of a compliance certificate pertaining to the quarter ended December 31, 2025. This certificate, issued by KFin Technologies Limited, the company’s Registrar and Share Transfer Agent (RTA), confirms adherence to regulatory standards.
Details of the Certificate
The certificate specifically addresses compliance with the requirements regarding dematerialization and rematerialization of securities. This ensures that all such activities conducted during Q3 2026 (October-December) were performed in accordance with applicable Securities and Exchange Board of India (SEBI) regulations. The certificate has been furnished to the stock exchanges.
Importance of Compliance
Receiving this certificate demonstrates Dr. Agarwal’s Health Care Limited’s commitment to maintaining regulatory compliance and transparency in its securities-related operations. This confirmation provides assurance to investors regarding the proper handling of their securities and the company’s adherence to established guidelines.
Source: BSE
